| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in the computational landscape for repurposed drugs against COVID-19
|
Aronskyy, Illya
|
|
|
26 |
12 |
p. 2800-2815
|
artikel
|
| 2 |
ATP as an anti-aging agent: Beyond the energy reservoir
|
Chu, Xin-Yi
|
|
|
26 |
12 |
p. 2783-2785
|
artikel
|
| 3 |
Blocking the inflammasome: A novel approach to treat uveitis
|
Shome, Avik
|
|
|
26 |
12 |
p. 2839-2857
|
artikel
|
| 4 |
Contents page 1
|
|
|
|
26 |
12 |
p. i
|
artikel
|
| 5 |
Contents page 2
|
|
|
|
26 |
12 |
p. ii
|
artikel
|
| 6 |
F-box proteins in cancer stemness: An emerging prognostic and therapeutic target
|
Khan, Abdul Q.
|
|
|
26 |
12 |
p. 2905-2914
|
artikel
|
| 7 |
G-protein-coupled receptors as therapeutic targets for glioblastoma
|
Byrne, Kate F.
|
|
|
26 |
12 |
p. 2858-2870
|
artikel
|
| 8 |
2020 in review: FDA approvals of new medicines
|
Kinch, Michael S.
|
|
|
26 |
12 |
p. 2794-2799
|
artikel
|
| 9 |
Positive AMPA receptor modulation in the treatment of neuropsychiatric disorders: A long and winding road
|
Kadriu, Bashkim
|
|
|
26 |
12 |
p. 2816-2838
|
artikel
|
| 10 |
Social media mining in drug development—Fundamentals and use cases
|
Koss, Jonathan
|
|
|
26 |
12 |
p. 2871-2880
|
artikel
|
| 11 |
Systematic risk identification and assessment using a new risk map in pharmaceutical R&D
|
Schuhmacher, Alexander
|
|
|
26 |
12 |
p. 2786-2793
|
artikel
|
| 12 |
The forced swim test has poor accuracy for identifying novel antidepressants
|
Trunnell, Emily R.
|
|
|
26 |
12 |
p. 2898-2904
|
artikel
|
| 13 |
Therapeutic potential of nanoemulsions as feasible wagons for targeting Alzheimer’s disease
|
Handa, Mayank
|
|
|
26 |
12 |
p. 2881-2888
|
artikel
|
| 14 |
The rise and rise of protein degradation: Opportunities and challenges ahead
|
Hughes, Scott J.
|
|
|
26 |
12 |
p. 2889-2897
|
artikel
|
Tijdschrift beschrijving